Article
Influence of uridine diphosphate-glucuronosyltransferases (1A9) polymorphisms on mycophenolic acid pharmacokinetics in patients with renal transplant.
Renal failure - 1 Nov 2018
Ciftci H S, Demir E, Karadeniz M S, Tefik T, Nane I, Oguz F S, Aydin F, Turkmen A
Abstract excerpt
BACKGROUND: There are differences in pharmacokinetic of mycophenolic acid among individuals. The UGT1A9 enzyme is of special interest since it is the main enzyme involved in the glucuronidation of MPA. Single nucleotide polymorphisms in the UGT1A9 gene may be responsible for individual differences in the pharmacokinetics of MPA. The aim of this study was to explain MPA pharmacokinetics in UGT1A9 1399 C > T...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.